In 2020, two Georgia Tech grads, Vedant Pradeep and Shivani Shah, decided to treat alcohol use like an engineering problem instead of a moral failing.
They pulled from neuroscience and psychiatry, not willpower memes, and built Reframe: an app designed to help people literally rewire how their brains respond to alcohol.
The mission was simple and specific—use evidence-based habit change to help people rethink their relationship with drinking, without forcing them into an all-or-nothing box.
From Hundreds to Millions: The Real Reach of Reframe’s Neuroscience Approach
Reframe started as a digital program, but it didn’t stay small for long.
In a few years, the Reframe healthtech startup has grown to more than three million users and helped eliminate nearly half a billion drinks, according to recent coverage of their Dry January data and growth metrics in Hypepotamus.
That’s not just a marketing number; it’s a feedback loop of behavior data, cravings, slip-ups, and small wins at real scale.
The app itself doesn’t look like a traditional “sobriety tracker.”
It’s built around personalized programs that adapt to your goals—cutting back, pausing, or quitting—and it combines neuroscience-based lessons, daily check-ins, and cognitive behavioral tools.
On top of that, there’s a strong community layer: group challenges, peer support, and coaches who make the experience feel less like a solo struggle and more like a shared project.
That combination—personalized content plus community—has helped Reframe stand out in a crowded alcohol reduction space.
They’re not just logging drinks; they’re trying to change the emotional and cognitive patterns that drive drinking in the first place, something Atlanta Magazine highlighted in its profile of the founders’ neuroscience-driven approach.
It’s closer to a structured behavior-change program than a self-help app.
Investors noticed.
Reframe has raised more than $27 million, with backing from major funds that normally gravitate toward big TAM, data-rich, defensible plays.
For a consumer app focused on alcohol reduction, that level of funding signals something important: this isn’t just a niche wellness tool, it’s a platform with serious health and data implications.
Liquid Luck: Meeting Demand with Functional Beverages Beyond the Screen
Once you have millions of people logging cravings and triggers every day, you start to see patterns.
One of Reframe’s biggest: users weren’t just asking for content or coaching; they were asking what to drink instead of alcohol—especially at night, at social events, and during stress spikes.
That’s where Liquid Luck came from.
Instead of staying purely digital, Reframe launched a line of functional non-alcoholic beverages designed to help with cravings and relaxation.
These aren’t just “mocktails” with nice branding; they’re infused with ingredients aimed at reducing cravings and supporting the same habit-change goals the app focuses on.
It’s a direct response to user behavior, not a random CPG side quest.
The product expansion fits tightly with the app’s core thesis: habits are easier to change when you change the environment.
Reframe already helps users plan for triggers, rehearse responses, and build new routines around evenings and social time.
Liquid Luck gives them a physical tool to plug into those routines—a replacement behavior that aligns with the neuroscience instead of fighting it.
Strategically, this is where the story gets interesting for founders.
Reframe didn’t have to guess at demand for functional non-alcoholic beverages; they had millions of data points and direct user requests.
They also had a built-in distribution channel: an engaged app community that trusts the brand and is already in the mindset of changing their drinking habits, which Hypepotamus noted when covering the Liquid Luck launch.
That means their e-commerce motion isn’t cold-start DTC.
It’s layered on top of an existing relationship, with the app acting as both acquisition and retention engine for the beverage line.
For a healthtech company, that’s a rare and powerful bridge between software and physical product.
Why Reframe’s Data-First, Community-Centered Model Defies AI Disruption
On paper, Reframe looks like the kind of product AI could “disrupt”: content, recommendations, check-ins, coaching.
In practice, their moat is less about the content itself and more about the behavioral analytics and community wrapped around it.
Every check-in, craving log, and mood entry feeds a dataset that informs what they build next.
That data doesn’t just optimize push notifications.
It tells them when people are most likely to relapse, what events spike cravings, what kind of support works best at different stages, and which interventions actually move the needle on reduced drinking.
Liquid Luck is one example of a product born from that insight; there are likely more to come.
Crucially, Reframe’s model is built around managing emotions and building habits, not just surfacing AI-driven suggestions.
You can have the smartest recommendation engine in the world, but if someone is anxious, lonely, or stressed at 9:30 p.m., a generic “you got this” notification isn’t enough.
Reframe leans into structured habit loops, emotional regulation tools, and peer accountability—things that are harder to commoditize with a chatbot.
The community piece also matters.
People trying to change their relationship with alcohol often don’t want to walk into a meeting or broadcast it on social media.
A semi-anonymous, app-native community gives them a middle ground: real humans, shared experience, and a sense that they’re not the only ones doing this.
For founders, this is a useful pattern.
Reframe isn’t betting on AI as the product; they’re using data to make a very human process—behavior change—more predictable and more supportive.
That’s a blueprint for healthtech in crowded markets: build around outcomes, emotions, and habits first, then let AI and analytics support that, not replace it.
From Neuroscience to New Markets: What Reframe’s Journey Means for Healthtech Founders
Reframe’s path is pretty straightforward when you strip away the buzzwords.
They started with a focused, science-backed digital tool aimed at one hard problem: helping people drink less using neuroscience and psychiatry.
Then they listened to users, watched the data, and expanded into a physical product line that solved a concrete gap—what to drink instead.
The throughline is pragmatic, not visionary.
They didn’t pivot away from their mission; they deepened it by adding a new channel that supported the same behavioral goal.
The app and the beverages are two sides of the same habit-change system.
If you’re building in healthtech, there are a few clear signals here.
First, user behavior data is more than a retention dashboard; it’s a product roadmap if you’re willing to read it closely.
Second, community and emotional context are defensible assets in a world where AI can clone surface-level features overnight.
And third, you don’t have to stay “pure software” to be a serious tech company.
Sometimes the most logical move is to ship something physical that fits into the daily rituals you’re trying to change, especially in areas like sleep, nutrition, addiction, or stress.
Reframe shows that a healthtech startup can start in neuroscience, grow through software, and then step confidently into new markets—without losing the core mission that made it work in the first place.
